95 related articles for article (PubMed ID: 1528926)
1. Comparable oncogene and tumor suppressor gene alterations in rat and human osteosarcomas.
Isfort RJ; Cody DB; Lovell G; Doersen CJ
Prog Clin Biol Res; 1992; 376():321-30. PubMed ID: 1528926
[No Abstract] [Full Text] [Related]
2. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
3. [Oncogenes and suppressor genes in the genesis and progression of solid tumors in children].
Tonini GP; Mazzocco K; Scaruffi P
Pediatr Med Chir; 1994; 16(3):203-9. PubMed ID: 7971441
[TBL] [Abstract][Full Text] [Related]
4. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
[TBL] [Abstract][Full Text] [Related]
5. The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs: its role in the improvement of selective toxicity and the development of new drugs in clinical oncology.
Petty RD
Clin Oncol (R Coll Radiol); 1996; 8(3):186-9. PubMed ID: 8814375
[No Abstract] [Full Text] [Related]
6. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
7. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
Elliott K; Ge K; Du W; Prendergast GC
Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
[TBL] [Abstract][Full Text] [Related]
8. Analysis of oncogenes, tumor suppressor genes, autocrine growth-factor production, and differentiation state of human osteosarcoma cell lines.
Isfort RJ; Cody DB; Lovell G; Doersen CJ
Mol Carcinog; 1995 Nov; 14(3):170-8. PubMed ID: 7576109
[TBL] [Abstract][Full Text] [Related]
9. The evidence for human tumor suppressor genes.
Stanbridge EJ
Princess Takamatsu Symp; 1989; 20():3-13. PubMed ID: 2577336
[TBL] [Abstract][Full Text] [Related]
10. Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland.
Holm R; Nesland JM
J Pathol; 1994 Mar; 172(3):267-72. PubMed ID: 8195930
[TBL] [Abstract][Full Text] [Related]
11. Expression of ras Rb1 and p53 proteins in human breast cancer.
Spandidos DA; Karaiossifidi H; Malliri A; Linardopoulos S; Vassilaros S; Tsikkinis A; Field JK
Anticancer Res; 1992; 12(1):81-9. PubMed ID: 1567185
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of p53 and c-myc proteins in canine mammary tumours.
Inoue M; Shiramizu K
J Comp Pathol; 1999 Feb; 120(2):169-75. PubMed ID: 10087490
[TBL] [Abstract][Full Text] [Related]
13. Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line.
Ookawa K; Tsuchida S; Adachi J; Yokota J
Oncogene; 1997 Mar; 14(12):1389-96. PubMed ID: 9136982
[TBL] [Abstract][Full Text] [Related]
14. Amplification and overexpression of genes in 17p11.2 ~ p12 in osteosarcoma.
van Dartel M; Hulsebos TJ
Cancer Genet Cytogenet; 2004 Aug; 153(1):77-80. PubMed ID: 15325100
[TBL] [Abstract][Full Text] [Related]
15. [Recent advances in gene change of pancreatic cancer].
Wang YY; Cui QC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
[TBL] [Abstract][Full Text] [Related]
16. Sensitization and caffeine potentiation of cisplatin cytotoxicity resulting from introduction of wild-type p53 gene in human osteosarcoma.
Tsuchiya H; Mori Y; Ueda Y; Okada G; Tomita K
Anticancer Res; 2000; 20(1A):235-42. PubMed ID: 10769661
[TBL] [Abstract][Full Text] [Related]
17. The properties of p53 proteins selected for the loss of suppression of transformation.
Olson DC; Levine AJ
Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
[TBL] [Abstract][Full Text] [Related]
18. State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines.
Kim MS; Li SL; Bertolami CN; Cherrick HM; Park NH
Anticancer Res; 1993; 13(5A):1405-13. PubMed ID: 8239512
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells.
Terada N; Lucas JJ; Gelfand EW
J Immunol; 1991 Jul; 147(2):698-704. PubMed ID: 1906503
[TBL] [Abstract][Full Text] [Related]
20. [Oncogenes and tumor suppressor genes in head and neck squamous cell carcinomas].
Maestro R; Dolcetti R
Acta Otorhinolaryngol Ital; 1996 Jun; 16(3 Suppl 54):21-6. PubMed ID: 9036736
[No Abstract] [Full Text] [Related]
[Next] [New Search]
